Free Trial

BioXcel Therapeutics (BTAI) Earnings Date, Estimates & Call Transcripts

BioXcel Therapeutics logo
$0.64
-0.02 (-3.02%)
(As of 11/1/2024 ET)

BioXcel Therapeutics Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 12Estimated
Actual EPS
(Aug. 6)
-$0.21 Beat By $0.55
Consensus EPS
(Aug. 6)
-$0.76

BioXcel Therapeutics posted Q2 2024 earnings on August 6, 2024, reporting an EPS of -$0.21, which topped analysts' consensus estimates of -$0.76 by $0.55. Quarterly revenue was reported to be $1.10 million, above analyst estimates of $0.80 million. With a trailing EPS of -$3.56, BioXcel Therapeutics' earnings are expected to grow next year, from ($1.97) to ($1.59) per share.

BTAI Upcoming Earnings

BioXcel Therapeutics' next earnings date is estimated for Tuesday, November 12, 2024, based off prior year's reporting schedules.

Get BioXcel Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioXcel Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BTAI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BTAI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioXcel Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.69-$0.69-$0.69
Q2 20241-$0.63-$0.63-$0.63
Q3 20241-$0.55-$0.55-$0.55
Q4 20241-$0.49-$0.49-$0.49
FY 20244-$2.36-$2.36-$2.36
Q1 20251-$0.45-$0.45-$0.45
Q2 20251-$0.45-$0.45-$0.45
Q3 20251-$0.39-$0.39-$0.39
Q4 20251-$0.28-$0.28-$0.28
FY 20254($1.57)($1.57)($1.57)

BioXcel Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024
(Estimated)
------- 
8/6/2024Q2 2024-$0.76-$0.21+$0.55-$0.21$0.80M$1.10M    
5/9/2024Q1 2024-$0.68-$0.87 -$0.19-$0.87$0.42M$0.58M    
3/12/2024Q4 2023-$0.98-$0.76+$0.22-$0.76$1.17M$0.38M
11/14/2023Q3 2023-$1.29-$1.72 -$0.43-$1.72$0.84M$0.34M
8/14/2023Q2 2023-$1.72-$1.83 -$0.11-$1.83$0.42M$0.46M    
5/8/2023Q1 2023-$1.56-$1.84 -$0.28-$1.84$0.50M$0.21M    
3/9/2023Q4 2022-$1.49-$1.95 -$0.46-$1.95$1.08M$0.24M    
11/10/2022Q3 2022-$1.34-$1.49 -$0.15-$1.49$3.05M$0.14M

BioXcel Therapeutics Earnings - Frequently Asked Questions

BioXcel Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on BTAI's earnings history.

In the previous quarter, BioXcel Therapeutics (NASDAQ:BTAI) reported ($0.21) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.76) by $0.55. Learn more on analysts' earnings estimate vs. BTAI's actual earnings.

The conference call for BioXcel Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for BioXcel Therapeutics's latest earnings report can be read online.
Read Transcript

BioXcel Therapeutics (NASDAQ:BTAI) has a recorded annual revenue of $2.40 million.

BioXcel Therapeutics (NASDAQ:BTAI) has a recorded net income of -$179.05 million. BTAI has generated -$3.56 earnings per share over the last four quarters.

BioXcel Therapeutics's earnings are expected to grow from ($1.97) per share to ($1.59) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BTAI) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners